Radioiodine Therapy for Hyperthyroidism in a Patient with End-Stage Renal Disease on Hemodialysis: Case Report
PDF
Cite
Share
Request
Case Reports
VOLUME: 10 ISSUE: 2
P: 75 - 77
June 2014

Radioiodine Therapy for Hyperthyroidism in a Patient with End-Stage Renal Disease on Hemodialysis: Case Report

Med J Bakirkoy 2014;10(2):75-77
1. Okmeydanı Eğitim ve Araştırma Hastanesi, Nükleer Tıp Bölümü, İstanbul
No information available.
No information available
Received Date: 01.09.2011
Accepted Date: 07.04.2013
PDF
Cite
Share
Request

ABSTRACT

Toxic nodular goiter is a rare entity in end-stage renal disaese (ESRD) patients. In ESRD patients, hypothyroidism is generally seen, whereas hyperthyroidism is rare. Treatment with radioactive iodine (RAI) may be necessary for hyperthyroidism in patients with end-stage renal disease who require haemodialysis. Because RAI is cleared mainly by the kidneys in patients with normal renal function, many problems may (issues) arise in patients who are on hemodialysis but require RAI treatment. We present an ESRD patient with hyperthyroidism who is receiving hemodialysis treated with radioiodine therapy.

Keywords:
Hyperthyroidism, hemodialysis, radioiodine theraphy